Prediction of Pulmonary Problems
1 other identifier
observational
24
1 country
1
Brief Summary
The aim of this study was to examine the relationship between respiratory muscle strength and grip strength, muscle strength, oxygen saturation of peripheral muscles, dyspnea and respiration, cough, and health-related quality of life in individuals with Interstitial Lung Disease Associated with Rheumatoid Arthritis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedFirst Submitted
Initial submission to the registry
June 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedAugust 7, 2025
May 1, 2025
1 month
June 20, 2025
August 6, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Evaluation of respiratory muscle strength
One of the most commonly used and noninvasive methods for assessing respiratory muscle strength is the measurement of MIP and MEP. Respiratory muscle strength was measured using a portable, electronic, oral pressure measuring device (Micro Medical MicroMPM, UK). These are intraoral pressures measured during maximal inspiration against a valve that closes the airway during maximum inspiration and expiration.
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
Oxygen Saturation Measurement
Oxygen saturation measurement was performed with the MOXY (Fortiori Design LLC., Minnesota, USA) device. MOXY is a medical device with dimensions of 61x44x21 mm and a weight of 42 gr. It is an infrared measurement device called "near infrared spectroscopy" that measures oxygen saturation and total hemoglobin in muscle capillaries.
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
Secondary Outcomes (8)
Modified Borg Scale
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
Modified Medical Research Council Dyspnea Scale
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
Visual Analog Scale
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
Leicester Cough Survey
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
St. George's Respiratory Survey
Evaluations started immediately after receiving ethics committee approval and will be completed within 1 months, which is the study period.
- +3 more secondary outcomes
Eligibility Criteria
Patients with rheumatoid arthritis-associated interstitial lung disease follow-up at Pamukkale University Hospital
You may qualify if:
- ≥18 individuals diagnosed with RA by the same rheumatologist based on published results
You may not qualify if:
- Individuals with \>10 pack-year smoking history
- Severe functional limitations
- Cardiopulmonary and/or neurological disease unrelated to RA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zülal TATARlead
Study Sites (1)
Pamukkale University
Denizli, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
June 20, 2025
First Posted
July 2, 2025
Study Start
May 16, 2025
Primary Completion
June 15, 2025
Study Completion
June 25, 2025
Last Updated
August 7, 2025
Record last verified: 2025-05